Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sernaz Uzunoglu

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
European Radiology|November 14, 2013
Incidence of contrast-induced nephropathy in hospitalised patients with cancerIrfan Cicin, Bulent Erdogan, Emrah Gulsen, et al.
Hepato-Gastroenterology|February 24, 2016
Primary Tumor Resection Offers Higher Survival Advantage in KRAS Mutant Metastatic Colorectal Cancer PatientsHilmi Kodaz, Bulent Erdogan, Ilhan Hacibekiroglu, et al.
Acta Gastro-Enterologica Belgica|July 8, 2016
Post progression survival analysis of metastatic gastric and gastroesophageal junction cancer patients after second-line treatmentEsma Turkmen, Bulent Erdogan, Hilmi Kodaz, et al.
Molecular and Clinical Oncology|December 2, 2015
Comparative analysis of the efficacy and safety of modified FOLFOX-6 and DCF regimens as first-line treatment in advanced gastric cancerIlhan Hacibekiroglu, Hilmi Kodaz, Bulent Erdogan, et al.
Molecular and Clinical Oncology|December 4, 2014
Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumorsHilmi Kodaz, Ilhan Hacibekiroglu, Bulent Erdogan, et al.
Onkologie|April 18, 2009
Synchronous tonsil, gallbladder, and cardiac metastases without any other visceral metastases of malignant melanomaIrfan Cicin, Ufuk Usta, Atakan Sezer, et al.
Medical Oncology (Northwood, London, England)|November 13, 2008
Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancerIrfan Cicin, Hakan Karagol, Ufuk Usta, et al.
Medical Oncology (Northwood, London, England)|December 16, 2014
Impact of bevacizumab on survival outcomes in primary tumor resected metastatic colorectal cancerHilmi Kodaz, Bulent Erdogan, Ilhan Hacibekiroglu, et al.
Revista Portuguesa De Pneumologia|September 11, 2008
Inguinal lymph node as the only evidence of progressive lung cancerZafer Kocak, Mert Saynak, Fulya Oz-Puyan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 16, 2021
The relation between tissue galectin-3 level and platinum resistance in neoadjuvant bladder cancer treatmentAli Gokyer, Ahmet Kucukarda, Osman Kostek, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
European Radiology|November 14, 2013
Incidence of contrast-induced nephropathy in hospitalised patients with cancerIrfan Cicin, Bulent Erdogan, Emrah Gulsen, et al.
Hepato-Gastroenterology|February 24, 2016
Primary Tumor Resection Offers Higher Survival Advantage in KRAS Mutant Metastatic Colorectal Cancer PatientsHilmi Kodaz, Bulent Erdogan, Ilhan Hacibekiroglu, et al.
Acta Gastro-Enterologica Belgica|July 8, 2016
Post progression survival analysis of metastatic gastric and gastroesophageal junction cancer patients after second-line treatmentEsma Turkmen, Bulent Erdogan, Hilmi Kodaz, et al.
Molecular and Clinical Oncology|December 2, 2015
Comparative analysis of the efficacy and safety of modified FOLFOX-6 and DCF regimens as first-line treatment in advanced gastric cancerIlhan Hacibekiroglu, Hilmi Kodaz, Bulent Erdogan, et al.
Molecular and Clinical Oncology|December 4, 2014
Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumorsHilmi Kodaz, Ilhan Hacibekiroglu, Bulent Erdogan, et al.
Onkologie|April 18, 2009
Synchronous tonsil, gallbladder, and cardiac metastases without any other visceral metastases of malignant melanomaIrfan Cicin, Ufuk Usta, Atakan Sezer, et al.
Medical Oncology (Northwood, London, England)|November 13, 2008
Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancerIrfan Cicin, Hakan Karagol, Ufuk Usta, et al.
Medical Oncology (Northwood, London, England)|December 16, 2014
Impact of bevacizumab on survival outcomes in primary tumor resected metastatic colorectal cancerHilmi Kodaz, Bulent Erdogan, Ilhan Hacibekiroglu, et al.
Revista Portuguesa De Pneumologia|September 11, 2008
Inguinal lymph node as the only evidence of progressive lung cancerZafer Kocak, Mert Saynak, Fulya Oz-Puyan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 16, 2021
The relation between tissue galectin-3 level and platinum resistance in neoadjuvant bladder cancer treatmentAli Gokyer, Ahmet Kucukarda, Osman Kostek, et al.
Pageof 4